Oxypoint

Oxypoint is an innovative company specializing in oxygen therapy, with a focus on faster recovery and improved outcomes for patients. The company's ultimate ambition is to offer an end-to-end patient monitoring and therapy management solution that spans from the hospital to the patient’s home, leveraging their oxygen management portfolio. Their first product line, O2COMFORT, shifts oxygen therapy into comfort mode by aligning oxygen delivery with the patient's natural breath rate. This approach not only enhances patient well-being but also reduces medical oxygen wastage. In the near future, Oxypoint plans to introduce new digital products that aim to revolutionize oxygen therapy by optimizing it through the capture of vital signs in both hospital and home settings, and by providing valuable insights to doctors, nurses, patients, and family. The company was founded in 2011 and operates in the Health Care and Medical Devices industries. Its headquarters are not specified. Oxypoint's most recent investment details and investors are currently undisclosed. As a medical devices startup, Oxypoint demonstrates a clear commitment to innovation and meeting the evolving demands of the healthcare sector. With its focus on improving patient outcomes and expanding its product offerings into the digital realm, Oxypoint presents an intriguing investment opportunity for venture capitalists looking to support the advancement of healthcare technologies. The company's track record of innovation and its potential to address critical needs in the medical field make it a compelling prospect for investment consideration.